Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with B Cell Lymphomas Participating in the PETAL Trial

Ulrich Duehrsen, MD, Stefan P Müller, MD, Jan Rekowski, Dipl.-Stat., Bernd Hertenstein, MD, Christiane Franzius, MD, Rolf Mesters, MD, Matthias Weckesser, MD, Frank Kroschinsky, MD, Jörg Kotzerke, MD, Anke Franzke, MD, Frank M Bengel, MD, Paul La Rosée, MD, Martin Freesmeyer, MD, Heinz-Gert Hoeffkes, MD, Andreas Hertel, MD, Dirk Behringer, Gabriele Prange-Krex, MD, Martin Griesshammer, MD, Jens Holzinger, MD, Stefan Wilop, MD, Thomas Krohn, MD, Aruna Raghavachar, MD, Georg Maschmeyer, MD, Ingo Brink, MD, Roland Schroers, MD, Tobias Gaska, MD, Tu-Anh Dang, MD, Aristoteles Giagounidis, Ariane Dienst, MD, Hubertus Hautzel, MD, Ralph Naumann, MD, Alfred Klein, MD, Dennis Hahn, MD, Gabriele Pöpperl, MD, Matthias Grube, MD, Jörg Marienhagen, MD, Andreas Schwarzer, MD, Lars Kurch, MD, Thomas Höhler, MD, Heike Steiniger, MD, Holger Nückel, MD, Thomas Südhoff, MD, Wolfgang Römer, MD, Marcus Brinkmann, Claudia Ose, Dieter Hoelzer, MD, Jan Dürig, MD, Karl-Heinz Jöckel, PhD, Wolfram Klapper, MD, Andreas Hüttmann, MD

Blood (2016) 128 (22): 1857.

https://doi.org/10.1182/blood.V128.22.1857.1857

Published: 2016

Journal Articles

CD49d Is The Strongest Flow Cytometry-Based Predictor Of Overall Survival In Chronic Lymphocytic Leukemia

Pietro Bulian, MD, Tait D Shanafelt, MD, Chris Fegan, MBBS, Antonella Zucchetto, Lilla Cro, PhD, Holger Nuckel, MD, Luca Baldini, Antonina Kurtova, MS, Alessandra Ferrajoli, MD, Jan A. Burger, MD, PhD, Gianluca Gaidano, Giovanni Del Poeta, MD, Chris Pepper, Ph.D., Davide Rossi, Valter Gattei

Blood (2013) 122 (21): 672.

https://doi.org/10.1182/blood.V122.21.672.672

Published: 2013

Journal Articles

Prognostic Relevance of CD49d Expression On B Leukemic Cells in Chronic Lymphocytic Leukemia. Meta-Analysis of Published and unpublished Individual Data From 3146 Patients

Pietro Bulian, MD, Tait D. Shanafelt, MD, Chris Pepper, Chris Fegan, Giovanni Del Poeta, Gianluca Gaidano, MD, PhD, Davide Rossi, MD, PhD, Luca Baldini, Lilla Cro, PhD, Holger Nuckel, MD, Jan A. Burger, MD, PhD, Valter Gattei, MD

Blood (2012) 120 (21): 3871.

https://doi.org/10.1182/blood.V120.21.3871.3871

Published: 2012

Journal Articles

A New MicroRNA Risk Model for Prediction of Clinical Outcome In Chronic Lymphocytic Leukemia

Holger Nuckel, MD, Crista Ochsenfarth, Ludger Sellmann, MD, Jan Duerig, MD, Ulrich Duehrsen, MD, Ulrich Frey, MD

Blood (2010) 116 (21): 3592.

https://doi.org/10.1182/blood.V116.21.3592.3592

Published: 2010

Journal Articles

Association of HLA-G Haplotype Risk Model with Treatment Free Survival In Chronic Lymphocytic Leukemia Patients

Johanna Kapp, Crista Ochsenfarth, Magdalena Switala, Ulrich Frey, MD, Ludger Sellmann, MD, Jan Duerig, MD, Peter A Horn, MD, Ulrich Duehrsen, MD, Vera Rebmann, PhD, Holger Nuckel, MD

Blood (2010) 116 (21): 2418.

https://doi.org/10.1182/blood.V116.21.2418.2418

Published: 2010

Journal Articles

Association of HLA-G Haplotype Risk Model with Overall Survival In Acute Myeloid Leukemia Patients

Anja Volbracht, Juergen R Novotny, MD, Crista Ochsenfarth, Magdalena Switala, Ulrich Frey, MD, Peter A Horn, MD, Ulrich Duehrsen, MD, Vera Rebmann, PhD, Holger Nuckel, MD

Blood (2010) 116 (21): 2169.

https://doi.org/10.1182/blood.V116.21.2169.2169

Published: 2010

Journal Articles

A variant allele of Growth Factor Independence 1 ( GFI1 ) is associated with acute myeloid leukemia

Blood (2010) 115 (12): 2462–2472.

https://doi.org/10.1182/blood-2009-08-239822

Published: 2010

Journal Articles

Prognostic Assessment of Three Single Nucleotide Polymorphisms ( BCL2 –938C>A, MTHFR 677C>T, GNAS1 T393C) in Chronic Lymphocytic Leukemia.

Thorsten Zenz, Ulrich Duehrsen, Harald Dohner, Winfried Siffert, Stephan Stilgenbauer, Holger Nuckel

Blood (2007) 110 (11): 2080.

https://doi.org/10.1182/blood.V110.11.2080.2080

Published: 2007

NARROW

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with B Cell Lymphomas Participating in the PETAL Trial

CD49d Is The Strongest Flow Cytometry-Based Predictor Of Overall Survival In Chronic Lymphocytic Leukemia

Prognostic Relevance of CD49d Expression On B Leukemic Cells in Chronic Lymphocytic Leukemia. Meta-Analysis of Published and unpublished Individual Data From 3146 Patients

A New MicroRNA Risk Model for Prediction of Clinical Outcome In Chronic Lymphocytic Leukemia

Association of HLA-G Haplotype Risk Model with Treatment Free Survival In Chronic Lymphocytic Leukemia Patients

Association of HLA-G Haplotype Risk Model with Overall Survival In Acute Myeloid Leukemia Patients

A variant allele of Growth Factor Independence 1 ( GFI1 ) is associated with acute myeloid leukemia

Prognostic Assessment of Three Single Nucleotide Polymorphisms ( BCL2 –938C>A, MTHFR 677C>T, GNAS1 T393C) in Chronic Lymphocytic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only